Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Disclaimer: The information provided by this service is for educational and informational purposes only and is not intended as medical advice
Treatment typically begins at a low dose (2.5 mg weekly) with gradual titration to minimize side effects
[2] Some individuals with genetic or medical disorders (such as preterm infants) cannot make enough carnitine, requiring dietary supplementation
70 HP 150 5-AMINO-1MQ Small-molecule NNMT inhibitor body-composition research ALIASES 5A1MQ, 5-amino-1-methylquinolinium iodide, NNMT inhibitor CLASS Small-molecule NNMT inhibitor (not a peptide) FORMULA C10H11IN2 HALF-LIFE Short plasma half-life (oral bioavailable) ROUTES Oral (in animal studies) Subcutaneous (research) MECHANISM OF ACTION 5-Amino-1-methylquinolinium iodide
Actual price may vary
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021: World Health Organization
